Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

X4 Pharmaceuticals Inc (XFOR)

X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
X4 Pharmaceuticals to Present Pivotal Phase 3 Trial Data for Mavorixafor at ASH Annual Meeting 2024 Quiver Quantitative, Inc. - Wed Dec 4, 5:20PM CST

X4 Pharmaceuticals announces presentations at the ASH Annual Meeting on mavorixafor for chronic neutropenia treatment.Quiver AI SummaryX4 Pharmaceuticals announced its participation in the 66th American...

XFOR : 0.5800 (+0.50%)
X4 Pharmaceuticals to Present Trial-in-Progress Poster on Phase 3 Study of Mavorixafor in Chronic Neutropenia at 66th ASH Annual Meeting & Exposition GlobeNewswire - Wed Dec 4, 7:00AM CST

XFOR : 0.5800 (+0.50%)
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Tue Dec 3, 3:05PM CST

XFOR : 0.5800 (+0.50%)
X4 Pharmaceuticals to Participate in the 36th Annual Piper Sandler Healthcare Conference GlobeNewswire - Tue Nov 26, 7:00AM CST

XFOR : 0.5800 (+0.50%)
X4 Pharmaceuticals to Participate in the Stifel 2024 Healthcare Conference GlobeNewswire - Thu Nov 14, 7:00AM CST

XFOR : 0.5800 (+0.50%)
X4 Pharmaceuticals: Q3 Earnings Snapshot AP - Wed Nov 13, 5:13AM CST

X4 Pharmaceuticals: Q3 Earnings Snapshot

XFOR : 0.5800 (+0.50%)
X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update GlobeNewswire - Wed Nov 13, 5:07AM CST

XFOR : 0.5800 (+0.50%)
X4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN) GlobeNewswire - Wed Nov 13, 5:01AM CST

XFOR : 0.5800 (+0.50%)
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Nov 1, 3:05PM CDT

XFOR : 0.5800 (+0.50%)
X4 Pharmaceuticals to Report Third-Quarter 2024 Financial and Phase 2 Chronic Neutropenia Study Results During Conference Call and Webcast on November 13, 2024 GlobeNewswire - Thu Oct 24, 7:00AM CDT

XFOR : 0.5800 (+0.50%)

Barchart Exclusives

Grupo Supervielle - Great Argentine Financial Company Barchart - Tue Dec 24, 7:00AM CST
The Chart of the Day belongs to the Argentine financial services stock Grupo Supervielle (SUPV) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot